Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05441514
Title Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center

acute myeloid leukemia


Cobimetinib + Enasidenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST